| |
Company
Roster
|
|
Total
Insiders : |
40 |
|
|
|
Total
Direct Shares :
|
12,175,286 |
|
|
Total
Indirect Shares :
|
18,192,536 |
| |
%
Held by Insiders:
|
27.54% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Read Randolph C |
Director |
2023-06-16 |
200,000 |
2020-11-16 |
0 |
| Bleznick Jordan |
Director |
2020-11-13 |
100,000 |
2020-11-13 |
0 |
| Pearce Michael Cooper |
See explanation of responses |
2020-08-05 |
0 |
2020-08-05 |
9,518,748 |
| Myrexis, Inc. |
10% Owner |
2020-03-26 |
4,717,666 |
2021-08-13 |
7,393,954 |
| Xstelos Corp. |
10% Owner |
2020-03-26 |
4,717,666 |
2020-03-26 |
1,033,264 |
| Lebuhn Robert |
Director |
2013-09-19 |
42,189 |
2004-07-01 |
0 |
| Conover Charles |
SVP, R&D Program Management |
2013-01-23 |
74,793 |
2012-01-17 |
1,158 |
| Rackear Andrew D |
VP and General Counsel |
2013-01-23 |
78,019 |
|
0 |
| Buchbinder Aby |
VP, Clinical Development |
2013-01-23 |
79,246 |
|
0 |
| Hebard George |
Interim PEO and Interim COO, Director |
2012-11-07 |
43,237 |
2012-02-27 |
0 |
| Salisbury Robert C |
Director |
2012-07-02 |
67,707 |
|
0 |
| Young Richard A |
Director |
2012-07-02 |
30,231 |
2010-04-19 |
0 |
| Mulligan Richard |
Director |
2012-07-02 |
49,064 |
2009-05-21 |
0 |
| Deuel Thomas |
Director |
2012-07-02 |
32,231 |
2010-04-19 |
0 |
| Denner Alexander J |
Director |
2012-07-02 |
60,620 |
2009-05-21 |
0 |
| Daly Timothy |
VP, Controller and PAO |
2012-03-28 |
8,000 |
2012-03-28 |
0 |
| Greenberger Lee M |
VP, Research |
2012-01-17 |
36,146 |
|
0 |
| Stancic Ana |
Executive VP, COO, PEO, CFO |
2012-01-17 |
70,000 |
2011-06-08 |
0 |
| Delcampo Ralph |
COO and Princ. Exec. Officer |
2011-09-15 |
204,633 |
|
0 |
| Davit Paul Stephen |
Exec. Vice Pres. HR |
2011-07-01 |
109,314 |
|
0 |
| Horak Ivan D |
EVP, R&D, CSO |
2011-04-03 |
138,476 |
2005-10-04 |
0 |
| Ogden Mark L |
Acting VP of Fin & Prin FO |
2011-02-28 |
4,000 |
|
0 |
| Micati Victor P |
Director |
2010-07-02 |
50,625 |
2004-11-11 |
0 |
| Classon Rolf A |
Director |
2010-07-02 |
55,320 |
2004-07-01 |
0 |
| Tooman Craig A |
Exec VP Finance, CFO |
2010-06-18 |
160,480 |
2005-01-05 |
0 |
| Buchalter Jeffrey H |
CEO & President, Director |
2010-01-27 |
529,259 |
2004-09-28 |
0 |
| Levy Harold J |
Director |
2009-07-23 |
50,000 |
2010-02-18 |
166,535 |
| Ando Goran |
Director |
2009-07-03 |
40,409 |
2004-11-11 |
0 |
| Renfro Phillip M |
Director |
2008-11-14 |
25,973 |
2005-01-04 |
0 |
| Geltosky John |
Director |
2008-07-01 |
18,760 |
2008-07-01 |
0 |
| Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
2007-07-11 |
0 |
2007-08-13 |
0 |
| Swieca Henry |
10% Owner |
2007-04-09 |
0 |
2007-04-11 |
0 |
| Highbridge Capital Corp |
10% Owner |
2007-02-15 |
0 |
2007-02-15 |
0 |
| Dixon Rosina B |
Director |
2005-01-18 |
55,433 |
2005-01-18 |
500 |
| Golde David |
Director |
2004-07-01 |
3,268 |
2004-07-01 |
39,100 |
| Higgins Arthur J |
Director |
2004-07-01 |
240,072 |
2004-07-01 |
0 |
| Zuerblis Kenneth J |
Executive V.P., Finance, CFO |
2004-06-14 |
35,330 |
2004-06-14 |
0 |
| Parkinson Robert L Jr |
Director |
2004-03-31 |
6,738 |
2004-03-31 |
0 |
| Grau Ulrich M |
Chief Scientific Officer |
2003-12-05 |
40,381 |
2003-12-05 |
0 |
| Icahn Carl C Et Al |
10% Owner |
|
0 |
2020-10-09 |
39,277 |
|
0.01 (12.87%) 
